500+
Scientists Trained Worldwide
15+
Years Experience
3
Major Pharma Companies
100%
Clinical Focus

MD-PhD Expertise at Your Service

🧬

Clinical & Research Excellence

Unique combination of MD clinical knowledge and PhD research expertise in tumor immunology, ensuring both scientific rigor and practical clinical application.

🔬

Advanced Cytometry Mastery

Mass cytometry (CyTOF) expert and co-author of Cytofast R package. Custom analysis pipelines with AI-enhanced data interpretation for breakthrough insights.

🎯

Industry-Proven Results

Track record with leading pharmaceutical companies including Novartis, UCB, and Merck Serono. Deep understanding of drug development and regulatory requirements.

🌟

Global Training Impact

500+ scientists trained worldwide in advanced cytometry techniques. Proven ability to translate complex concepts into actionable insights for diverse teams.

Academic & Industrial Experience

Medical Degree - Lille University

Comprehensive medical training with focus on oncology and patient care

PhD in Tumor Immunology - Leiden University Medical Center

Advanced research in tumor microenvironment and immune cell dynamics

Novartis - Monoclonal Antibody Development

Led development programs for innovative immunotherapy treatments

UCB - Center of Excellence, Antibody Expert

Strategic leadership in antibody research and development initiatives

Merck Serono - Production Optimization

Optimized manufacturing processes for biologic therapeutics

Specialized Consulting Services

Single-Cell Analysis

  • CyTOF study design and optimization
  • Custom analysis pipeline development
  • Advanced data visualization
  • Machine learning integration
  • Statistical modeling and interpretation

Immunotherapy Development

  • Treatment response monitoring
  • Tumor microenvironment analysis
  • Biomarker discovery and validation
  • Clinical trial design guidance
  • Clinical-research translation

Medical Oncology & Cancer Immunotherapy

  • Clinical trial design for cancer immunotherapy
  • Tumor microenvironment profiling
  • Immune checkpoint inhibitor optimization
  • CAR-T cell therapy development support
  • Resistance mechanism identification

Ideal For

🏢

Biotech Companies

Developing innovative immunotherapies and need expert guidance on cytometry-based efficacy assessment

💊

Pharmaceutical Companies

Running CyTOF studies and requiring specialized analysis expertise for drug development programs

🔬

Research Organizations

Academic institutions and research centers needing expert guidance on advanced cytometry applications

🏥

Hospital Research Centers

Clinical research departments seeking to implement cutting-edge cytometry techniques in translational studies

📊

Contract Research Organizations

CROs requiring technical expertise for complex immunology studies and regulatory submissions

Unique Value Proposition

The rare combination of clinical oncology knowledge with cutting-edge single-cell analysis expertise creates unparalleled value for your immunotherapy development pipeline.

This unique perspective ensures that every analysis is not just technically sophisticated, but clinically relevant and actionable for patient care and regulatory success.